Clinical Trials Logo

Urethral Stricture clinical trials

View clinical trials related to Urethral Stricture.

Filter by:

NCT ID: NCT05069883 Completed - Recurrence Clinical Trials

Role of Oral Steroids in Reducing Recurrence of Urethral Stricture After Direct Vision Internal Urethrotomy

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

It was a randomized controlled trial conducted at department of Urology, Armed Forces Institute of Urology, Rawalpindi from 1st January, 2018 July 2019 to 31st March 2021 to determine the role of oral steroids after Direct Vision Internal Urethrotomy to reduce the recurrence rate of urethral strictures.

NCT ID: NCT04965025 Recruiting - Urethral Stricture Clinical Trials

Multi-stage Urethroplasty With Augmentation Using a Dorsal Graft Inlay Technique Comparing Graft Use in First or Second Stage

MAGIC I
Start date: November 11, 2020
Phase: N/A
Study type: Interventional

The principal aim of this pilot study is to directly compare both approaches and analyze the failure rate after one year of follow-up. These data will serve as the basis to design a larger phase II or III trial in the future with failure rate as the primary end-point. Other study objectives are thoroughly described underneath.

NCT ID: NCT04795570 Recruiting - Fibrosis Clinical Trials

Urethral Stricture After Transurethral Resection of the Prostate/Bladder: a Prospective Study of Risk Factors

STRICT-TURP
Start date: September 1, 2020
Phase:
Study type: Observational

There is currently no prognostic or predictive risk marker for this urethral stricture disease. The most conservative standard treatment for urethral stricture (internal urethrotomy) has a very high recurrence rate (greater than 75%) and, on many occasions, reconstructive urologists have to choose within a great variety of further complex interventions. Knowing risk and predictive markers of this disease could help to optimize both the need and the approach for these surgeries and may offer a more individualized management to patients.

NCT ID: NCT04650347 Completed - Clinical trials for Urethral Stricture, Male

Holmium: YAG Versus Cold Knife Internal Urethrotomy in Management of Short Urethral Strictures

Start date: March 1, 2017
Phase: Phase 2/Phase 3
Study type: Interventional

Urethral stricture disease is defined as narrowing of the urethral lumen because of fibrosis, which occurs in urethral mucosa and surrounding tissues. The etiology could be congenital, iatrogenic, infectious, or idiopathic. Several techniques are currently available for minimally invasive treatment of urethral strictures, including cold-knife incision, electrocautery, and various types of laser incisions. An incision with the cold knife does not cause any thermal effect on surrounding tissues but should create a mechanical injury that may lead to recurrence in long term. An incision with the electrocautery should cause a significant thermal effect on healthy surrounding tissues resulting in recurrent strictures during follow-up. Laser treatment modalities have gained popularity in the last two decades. the aim of this trial is to evaluate the safety and efficacy of endo-urethrotomy with Holmium laser and cold knife endo-urethrotomy

NCT ID: NCT04551417 Recruiting - Urethra Stenosis Clinical Trials

DoVe Trial: Dorsal Onlay Versus Ventral Onlay in Isolated Bulbar Urethral Strictures

DoVe
Start date: March 4, 2020
Phase: N/A
Study type: Interventional

For bulbar urethral strictures, it remains unclear whether ventral onlay graft urethroplasty is non-inferior to dorsal onlay graft urethroplasty in terms of patency rates.

NCT ID: NCT04452890 Completed - Clinical trials for Anterior Urethral Stricture, Male

Pre-operative Assessment by Sonourethrography Only in Anterior Urethral Strictures.

PASTIS
Start date: July 1, 2020
Phase: N/A
Study type: Interventional

The choice of the best surgical technique for urethral stricture repair depends on the stricture length. Estimating the length of urethral strictures is therefore of utmost importance. Different clinical studies have proven that SUG has a higher sensitivity to evaluate the length of urethral strictures compared to RUG or VCUG. The goal of this study is to assess the feasibility of using SUG as single pre-operative assessment tool in patients with suspicion of anterior urethral strictures. In this way, use of RUG and/or VCUG could be omitted in the pre-operative work-up of patients with anterior urethral strictures, thereby avoiding significant radiation load of patients.

NCT ID: NCT04357080 Completed - Urethral Stricture Clinical Trials

Factors Predicting Urethral Stricture Recurrence After Dorsal Onlay Augmented, Buccal Mucosal Graft Urethroplasty

Start date: July 15, 2020
Phase:
Study type: Observational

In this observational study, the investigators will evaluate potential risk factors associated with urethral stricture recurrence after augmentation anterior urethroplasty using dorsal onlay buccal mucosal Graft during the past 10 years. Patients' medical files will be reviewed for data relevant to demographics, clinical and operative characteristics. data will be analyzed using the appropriate statistical tests and the independent predictors of urethroplasty outcome will be identified.

NCT ID: NCT04307537 Completed - Urethral Stricture Clinical Trials

Post-Operative Imaging After Urethroplasty With Peri-catheter Retrograde Urethrography Or Trial of Voiding With Voiding Cysto-urethrography

POIROT
Start date: January 21, 2020
Phase: Phase 2
Study type: Interventional

After a reconstructive procedure of the urethra, a transurethral catheter is usually left in place to allow adequate healing of the tissues without exposure to urine. After 7-21 days, depending on several variables (e.g. type of reconstruction, stricture etiology, …), removal of the transurethral catheter is foreseen. However, in order to do so, the clinician first wants to objectify whether the urethra has indeed healed sufficiently and therefore he/she can rely on early postoperative imaging. Up until today, there is no clear standard about when and how to do early postoperative imaging and current practices are mainly based on expert opinion and habit. Basically, two strategies can be found amongst different urethroplasty centers: peri-catheter retrograde urethrography (pcRUG) and voiding cysto-urethrography (VCUG). A pcRUG is performed by placing a small caliber tube (e.g. feeding tube 5 Fr) in the meatus urethrae of the patient, next to the transurethral catheter (which remains in place), and injecting contrast alongside the catheter. With a VCUG, contrast is injected through the transurethral catheter, up to the bladder. Thereafter, the catheter is removed and the patient is asked to urinate and thus to pass contrast through the urethra. The primary end-point of this study is to compare 'the rightful decision to maintain the catheter at the time of imaging' between pcRUG only and pcRUG followed by VCUG in a within-patient fashion.

NCT ID: NCT04161365 Recruiting - Urethral Stricture Clinical Trials

Feasibility and Therapeutic Potential of Free Fat Grafts in the Treatment of Urethral Strictures

UREGRAFT
Start date: May 28, 2021
Phase: N/A
Study type: Interventional

In this study the investigators investigate the feasibility and therapeutic potential of free autologous fat grafting combined to direct visual urethrotomy (DVIU) in the treatment of urethral strictures.

NCT ID: NCT04071925 Recruiting - Urethral Stricture Clinical Trials

9000 URETHRA STUDY: a Study About Urethroplasty for Urethral Stricture Disease

Start date: September 1, 2019
Phase:
Study type: Observational

It has been demonstrated that urethroplasty should be considered the gold standard treatment for urethral stricture disease as it yields higher long-term success rates than endoscopic treatment options such as direct vision internal urethrotomy (DVIU) or dilation. Many data about these procedures exist, although most of the publications about urethroplasty are retrospective and involve a tremendous risk of bias. To address these issues, this study is designed to prospectively gain evidence about this matter in all patient subgroups facing a potential treatment with urethroplasty: native men, native women, transmen, transwomen and children.